APA Zitierstil

Emmenegger, M., Emmenegger, V., Shambat, S. M., Scheier, T. C., Gomez-Mejia, A., Chang, C., . . . Frauenknecht, K. B. M. (2023). Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk. Clinical immunology (Orlando, Fla.), 257, 109845. https://doi.org/10.1016/j.clim.2023.109845

Chicago Zitierstil

Emmenegger, Marc, et al. "Antiphospholipid Antibodies Are Enriched Post-acute COVID-19 but Do Not Modulate the Thrombotic Risk." Clinical Immunology (Orlando, Fla.) 257 (2023): 109845. https://dx.doi.org/10.1016/j.clim.2023.109845.

MLA Zitierstil

Emmenegger, Marc, et al. "Antiphospholipid Antibodies Are Enriched Post-acute COVID-19 but Do Not Modulate the Thrombotic Risk." Clinical Immunology (Orlando, Fla.), vol. 257, 2023, p. 109845.